Glucose-dependent insulinotropic polypeptide regulates dipeptide absorption in mouse jejunum

Area of Science:

• Gastroenterology
• Endocrinology
• Molecular Biology

Background:

• Glucose-dependent insulinotropic polypeptide (GIP) is crucial in glucose homeostasis and implicated in obesity and Type 2 diabetes.
• Previous research demonstrated GIP's role in activating Na-glucose cotransporter-1 (SGLT1) and enhancing glucose absorption.
• The regulatory effect of GIP on other intestinal nutrient transporters, specifically peptide absorption, remained uninvestigated.

Purpose of the Study:

• To investigate the effect of GIP on the proton-peptide cotransporter-1 (PepT1) in the mouse jejunum.
• To determine if GIP influences di- and tripeptide absorption mediated by PepT1.
• To elucidate the signaling pathway involved in GIP's regulation of PepT1.

Main Methods:

• Immunohistochemistry to localize GIP receptor (GIPR) and PepT1 proteins in mouse jejunum.
• Western blot analysis to identify protein expression of GIPR and PepT1.
• RT-PCR to confirm mRNA expression of GIPR and PepT1.
• Voltage-clamp techniques to measure Gly-Sar absorption and assess the effects of GIP, cephalexin, and RP-cAMP.

Main Results:

• GIPR and PepT1 proteins and mRNAs were detected in the mouse jejunum.
• GIP significantly activated the absorption of Gly-Sar, a substrate for PepT1.
• GIP-induced Gly-Sar absorption was dependent on cAMP signaling and was not mimicked by GLP-1.
• Cephalexin, a PepT1 inhibitor, blocked Gly-Sar absorption, confirming PepT1 mediation.

Conclusions:

• GIP directly activates PepT1-mediated peptide absorption in the jejunum.
• This activation occurs through a cAMP-dependent signaling pathway.
• Unlike GIP, GLP-1 does not appear to regulate PepT1 activity in the jejunum.